APM News and Press, Aptorum Group Limited From 02/03/22

Gainers: BioCardia (NASDAQ:BCDA) +30%. Aptorum Group (NASDAQ:APM) +22%. Bon Natural Life (NASDAQ:BON) +17%. Lightning eMotors (NYSE:ZEV) +15%. Modine Manufacturing (NYSE:MOD) +14%. Battalion Oil (NYSE:BATL) +13%. DXC Technology (NYSE:DXC) +12%. Redwire (NYSE:RDW) +11%. T-Mobile US (NASDAQ:TMU...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips SmileDirectClub (NASDAQ: SDC ) stock is soaring higher on Tuesday as investors celebrate a new strategic plan from the company. Source: Helen89 / Shutterstock.com According to the company, these plans include ...

In this article, we take a closer look at 5 penny stocks gaining ground after releasing big news today. Thanks to even more stock market uncertainty, retail traders have turned attention to daily trends, and rightfully so. The last week has seen markets pop and drop significant percentages ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: Eric Urquhart/Shutterstock.com There’s loads of movement from penny stocks t...

Trading Penny Stocks Today? Here’s What You Need to Know As morning trading gets off to a solid start for penny stocks and blue chips, there are quite a few things that investors need to know today. Recently, the Dow and S&P 500 were down by around 5% from the record highs th...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, is pleased to announce that the United States Food and Drug Administration (FDA) Office has granted Orpha...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office has granted the first patent regarding Apt...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including treatments and diagnosis of infectious diseases, announced that it...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces completion of the Phase I clinical trial for ALS-4 (a first in-class anti-virulence based small...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the launch of its oncology and autoimmune discovery and development platform with an initial fo...